Relationship between the Level of Circulating CD45+ Platelets and Development of Restenosis after Implantation of Drug-Eluting Stents to Patients with Coronary Heart Disease


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

The study was carried out in 126 patients with stable angina pectoris, who underwent elective coronary artery stenting with drug-eluting stents and follow-up angiography within 6-12 months thereafter. Five significant risk factors of restenosis were identified by binary comparisons of different variables. The logistic regression equation that included the level of CD45-positive platelets, diabetes, small vessel stenting, number of simultaneously implanted stents in one patient, and lesion length demonstrates the highest level of prediction of in-stent restenosis (OR=22.8; p<0.001). ROC-analysis demonstrated high prognostic value of the logit model (area under ROC curve 0.87, p<0.001). The data suggest that a close relationship exists between the development of restenosis and the level of circulating CD45+ platelets.

Об авторах

Z. Gabbasov

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Автор, ответственный за переписку.
Email: zufargabbasov@yandex.ru
Россия, Moscow

S. Kozlov

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: zufargabbasov@yandex.ru
Россия, Moscow

S. Byazrova

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: zufargabbasov@yandex.ru
Россия, Moscow

I. Mel’nikov

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: zufargabbasov@yandex.ru
Россия, Moscow

O. Saburova

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: zufargabbasov@yandex.ru
Россия, Moscow


© Springer Science+Business Media New York, 2017

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах